Tasquinimod Shows Some Activity in Myeloma

(MedPage Today) — In a study presented at the recent American Society of Clinical Oncology (ASCO) annual meeting, investigational tasquinimod showed early activity in relapsed/refractory multiple myeloma, with responses in patients resistant to…